News

Currently, the company is carrying out a randomized, double-blind, placebo-controlled Phase III clinical trial (VALOR), in patients with first relapsed or refractory acute myeloid leukemia (AML). A PIP

In the dose-escalation and dose-expansion stages of the trial assesing TH-302 and low-dose dexamethasone without bortezomib, patients were heavily-pretreated, and objective responses were observed in 5/16 patients treated

The once-daily, single-entity pain medication was formulated to include abuse-deterrent properties designed to make the product more difficult to manipulate for misuse or abuse by various routes of

As part of the deal, Rohto will assess stem cell-derived human cells owned and provided by ISCO in a number of pre-clinical animal models. The company said that

Bendamustine hydrochloride is a ready-to-dilute concentrate solution for injection that will be administered by infusion over 10 minutes after dilution in 50mL of sodium chloride (saline) or a

This USPTO issuance, combined with a similar success for a Chinese patent (ZL 200880124132.8) provides a solid foundation and protection for the company’s leading siRNA therapeutic project under

The company intends to initiate shipments of the product prior to the upcoming cough/cold/flu season. Advil Congestion Relief Tablets, 200mg/10mg, (ibuprofen & phenylephrine hydrochloride tablets, 200mg/10mg) is indicated

A new drug application was filed for the nonsteroidal anti-inflammatory drug (NSAID) with the Republic of Lebanon Ministry of Public Health (MOPH). ZORVOLEX was approved by the U.S.

The Company’s strategic research plan is designed to establish a series of inflammation assays and models with the goal of developing a hemp-extract profiling platform. This platform will